HIV testing and treatment among at-risk drinking injection drug users

Journal of the International Association of Physicians in AIDS Care

Volumn 8, Issue 3, 2009, Pages 196-201

  Arasteh, Kamyar ^a   Des Jarlais, Don C ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

alcohol use; antiretroviral treatment; At risk drinking; HIV; injection drug use

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ALCOHOLISM; ARTICLE; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICAL MODEL; SUBSTANCE ABUSE; UNITED STATES; VIROLOGY;

ADULT; ALCOHOLISM; ANTI-RETROVIRAL AGENTS; FEMALE; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MALE; NEW YORK CITY; QUESTIONNAIRES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 68149131462     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109709336222     Document Type: Article

References (20)

1. Mocroft A., Vella S., Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998 ; 352 (9142). 1725-1730. (Pubitemid 28534954)
2. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 ; 338 (13). 853-860. (Pubitemid 28135961)
3. Vittinghoff E., Scheer S., O'Malley P., Colfax G., Holmberg SD, Buchbinder SP Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999 ; 179 (3). 717-720. (Pubitemid 30016162)
4. Castilla J., Del Romero J., Hernando V., Marincovich B., Garcia S., Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005 ; 40 (1). 96-101. (Pubitemid 41233212)
5. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, U.S. Department of Health and Human Services, 2006.
6. Shapiro J., Vives G. Demographic and attitudinal variables related to high-risk behaviors in Asian males who have sex with other men. AIDS Patient Care STDS. 1999 ; 13 (11). 667-675. (Pubitemid 29534207)
7. Strathdee SA, Palepu A., Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998 ; 280 (6). 547-549. (Pubitemid 28377675)
8. Celentano DD, Vlahov D., Cohn S., Shadle VM, Obasanjo O., Moore RD Self-reported antiretroviral therapy in injection drug users. JAMA. 1998 ; 280 (6). 544-546.
9. Altice FL, Mostashari F., Friedland GH Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001 ; 28 (1). 47-58. (Pubitemid 33104527)
10. Palepu A., Horton NJ, Tibbetts N., Meli S., Samet JH Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004 ; 99 (3). 361-368. (Pubitemid 38333828)
11. Celentano DD, Vlahov D., Cohn S., Shadle VM, Obasanjo O., Moore RD Self-reported antiretroviral therapy in injection drug users. JAMA. 1998 ; 280 (6). 544-546.
12. Strathdee SA, Palepu A., Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998 ; 280 (6). 547-549. (Pubitemid 28377675)
13. McCance-Katz EF, Rainey PM, Friedland G., Jatlow P. The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis. 2003 ; 37 (4). 476-482. (Pubitemid 37011769)
14. Rainey PM, Friedland G., McCance-Katz EF, et al. Interaction of methadone with didanosine and stavudine. J Acquir Immune Defic Syndr. 2000 ; 24 (3). 241-248.
15. Panel on Clinical Practices for Treatment of HIV infection. Guidelines for the use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, U.S. Department of Health and Human Services, 2002.
16. Bogart LM, Kelly JA, Catz SL, Sosman JM Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr. 2000 ; 23 (5). 396-404. (Pubitemid 30431596)
17. Chander G., Lau B., Moore RD Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006 ; 43 (4). 411-417. (Pubitemid 44737097)
18. Dawson DA, Grant BF, Li TK Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res. 2005 ; 29 (5). 902-908. (Pubitemid 40686562)
19. National Institute on Alcohol Abuse and Alcoholism. Helping Patients with Alcohol Problems: A Health Practitioner's Guide. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism ; 2004.
20. SAS Institute. SAS/STAT software, version 9. Cary, NC: SAS Institute, Inc ; 2003.